Anuv Ratan

Anuv Ratan is an experienced professional with a strong background in the biopharma and medical device sectors. Currently serving as a Director at KKR & Co. Inc. since 2017, Anuv is also a Board Member for several organizations, including Immedica Pharma AB, Precipart, Biosynth, Dawn Biopharma, Sapphiros, and Gamma Biosciences, among others, focusing on rare diseases, precision components, life sciences, and clinical trial management. Additionally, Anuv holds positions as a Board Observer at Resolian and Cordis, contributing expertise in bioanalysis and interventional medical devices. Anuv is an alumnus of Harvard University.